Page last updated: 2024-08-24

cy 208-243 and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

cy 208-243 has been researched along with 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bédard, PJ; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B	1

Other Studies

1 other study(ies) available for cy 208-243 and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

Article	Year
Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors. Neuroscience letters, 1993, Nov-26, Volume: 163, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Female; GTP-Binding Proteins; Indoles; Macaca fascicularis; Neostriatum; Ovariectomy; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A	1993

Article

Year

Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.

Neuroscience letters, 1993, Nov-26, Volume: 163, Issue:1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Female; GTP-Binding Proteins; Indoles; Macaca fascicularis; Neostriatum; Ovariectomy; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A

1993